학술논문

Gilteritinib in combination with venetoclax, low-dose cytarabine and actinomycin D for relapsed or refractory FLT3-mutated acute myeloid leukaemia
Document Type
Article
Source
In: British Journal of Haematology. (British Journal of Haematology, April 2024, 204(4):1227-1231)
Subject
Language
English
ISSN
13652141
00071048